Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
30 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
23 déc. 2024 09h00 HE
|
Renovaro Inc
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
Renovaro Regains Compliance with NASDAQ Listing Requirement
20 déc. 2024 15h40 HE
|
Renovaro Inc
Renovaro Regains Compliance with NASDAQ Listing Requirement
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
20 déc. 2024 09h00 HE
|
Renovaro Inc
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
Renovaro Issues Shareholder Letter and Provides Corporate Update
04 nov. 2024 08h31 HE
|
Renovaro Inc
Renovaro Issues Shareholder Letter and Provides Corporate Update
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
17 oct. 2024 09h15 HE
|
Renovaro Inc
AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the...
Renovaro Announces Strategic Restructuring and Leadership Transition
16 oct. 2024 09h28 HE
|
Renovaro Inc
Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member SlateRealignment of Resources to Optimize and Commercialize...
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
19 sept. 2024 09h00 HE
|
Renovaro Inc
AMSTERDAM, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube’s AI-driven,...
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
17 sept. 2024 09h00 HE
|
Renovaro Inc
AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation...
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
13 sept. 2024 09h00 HE
|
Renovaro Inc
AMSTERDAM, Sept. 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) RenovaroCube (Cube, the Company), a leading AI-driven innovator using multi-omics technology for cancer profiling, is pleased to announce...